News

As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient ...
About a dozen activists from the Extinction Rebellion climate group briefly occupied the entrance lobby of French bank BNP ...
Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...
Recent health news includes major pharmaceutical listings in Hong Kong, a White House report on food and chemical impacts on ...
Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...
Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...
The U.S. Food and Drug Administration has cracked down on compounded drugs, which were readily available while the patented ...
Online prescriptions – for everything from weight loss to medicinal cannabis – is now a big business backed by Woolworths and ...
As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.